Advances in the treatment of hemorrhagic stroke: A possible new treatment

Cleveland Clinic Journal of Medicine

Volumn 72, Issue 4, 2005, Pages 341-344

  Broderick, Joseph P ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ARTICLE; BLOOD VESSEL INJURY; BRAIN HEMATOMA; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CRANIOTOMY; DOSE RESPONSE; DRUG HALF LIFE; DRUG MECHANISM; HEART INFARCTION; HUMAN; STROKE; THROMBOEMBOLISM;

EID: 17844377554     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.72.4.341     Document Type: Article

References (11)

1. Mayer SA, Brun NC, Begtrup K, et al, for the Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005; 352:777-785.
2. Mendelow DA, Gregson BA, Fernandes HM, et al for the STICH investigators. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 2005; 365:387-397.
3. Broderick JP, Adams HP, Barsan W, et al. Guidelines for the management of spontaneous intracerebral hemorrhage. A statement for healthcare professions from a special writing group of the Stroke Council, American Heart Association. Stroke 1999; 30:905-915.
4. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke 1993; 24:987-993.
5. Brott T, Broderick J, Kothari R, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997; 28:1-5.
6. Wagner KR, Xi G, Hua Y, et al. Ultra-early clot aspiration after lysis with tissue plasminogen activator in a porcine model of intracerebral hemorrhage: edema reduction and blood-brain barrier protection. J Neurosurg 1999; 90:491-498.
7. Gebel JM, Brott TG, Sila CA, et al. Decreased perihematomal edema in thrombolysis-related intracerebral hemorrhage compared with spontaneous intracerebral hemorrhage. Stroke 2000; 31:596-600.
8. Hoffman M, Monroe DM 3rd. A cell-based model of hemostasis. Thromb Haemost 2001; 85:958-965.
9. Mayer SA, Brun NC, Broderick J, et al; NovoSeven ICH Trial Investigators. Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage. Stroke. 2005; 36:74-79.
10. Teernstra O, Evers S, Lodder J, Leffers P, Franke C, Blaauw G. Sterotactic treatment of intracerebral hematoma by means of plasminogen activator: a multicentre randomized controlled trial (SICHPA). Stroke 2003; 34:968-974.
11. Hosseini H, Leguerinel C, Hariz M, et al. Sterotactic aspiration of deep intracerebral hematomas under computed tomographic control: a multicentric prospective randomized trial [abstract]. Presented at the 12 European Stroke Conference 2003, Valencia, Spain.